Found: 22
Select item for more details and to access through your institution.
Correction to: RE‑MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola‑BR), CAR‑T therapies, and lenalidomide/rituximab (R2) based on real‑world data in patients with relapsed/refractory diffuse large B‑cell lymphoma
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma
- Published in:
- Annals of Hematology, 2023, v. 102, n. 7, p. 1773, doi. 10.1007/s00277-023-05196-4
- By:
- Publication type:
- Article
Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 2, p. 1, doi. 10.1038/s41408-022-00620-w
- By:
- Publication type:
- Article
Poster: ABCL-346: Overall Survival with Tafasitamab + Lenalidomide (LEN) vs Routinely Administered Therapies for ASCT-Ineligible Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Outcomes from the Observational RE-MIND2 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S239, doi. 10.1016/S2152-2650(21)01499-3
- By:
- Publication type:
- Article
ABCL-346: Overall Survival with Tafasitamab + Lenalidomide (LEN) vs Routinely Administered Therapies for ASCT-Ineligible Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Outcomes from the Observational RE-MIND2 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S392, doi. 10.1016/S2152-2650(21)01891-7
- By:
- Publication type:
- Article
Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 6, p. 1, doi. 10.1038/s41408-021-00506-3
- By:
- Publication type:
- Article
How we treat mature B-cell neoplasms (indolent B-cell lymphomas).
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-01018-6
- By:
- Publication type:
- Article
Kinetics of pre‐myelodysplastic syndromes blood values correlate with disease risk and survival.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 5, p. 782, doi. 10.1002/hon.2777
- By:
- Publication type:
- Article
Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 7, p. N.PAG, doi. 10.1038/s41408-020-00340-z
- By:
- Publication type:
- Article
Gender differences in mortality among statin users aged 80 years or more.
- Published in:
- Zeitschrift für Gerontologie und Geriatrie, 2018, v. 51, n. 8, p. 880, doi. 10.1007/s00391-017-1335-y
- By:
- Publication type:
- Article
Can bone marrow cellularity help in predicting prognosis in myelodysplastic syndromes?
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 4, p. 502, doi. 10.1111/ejh.13134
- By:
- Publication type:
- Article
DA- EPOCH- R Treatment Can Cause Adrenal Insufficiency in Non-Hodgkin Lymphoma Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S270, doi. 10.1016/j.clml.2018.07.191
- By:
- Publication type:
- Article
Outcomes of second‐line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trials.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 3, p. 399, doi. 10.1111/ejh.13129
- By:
- Publication type:
- Article
Persistently low lymphocyte counts after FCR therapy for chronic lymphocytic leukemia are associated with longer overall survival.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Serum free immunoglobulin light chain fingerprint identifies a subset of newly diagnosed multiple myeloma patients with worse outcome.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The value of electrophysiologic study in decision-making regarding the need for pacemaker implantation after TAVI.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Continuing dilemmas in the management of lymphoma during pregnancy: review of a 10-point case-based questionnaire.
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 1, p. 190, doi. 10.1007/s10147-016-1036-3
- By:
- Publication type:
- Article
Expert guided natural language processing using one-class classification.
- Published in:
- Journal of the American Medical Informatics Association, 2015, v. 22, n. 5, p. 962, doi. 10.1093/jamia/ocv010
- By:
- Publication type:
- Article
Composite renal cell carcinoma and angiomyolipoma in a patient with Tuberous sclerosis: A diagnostic dilemma.
- Published in:
- Canadian Urological Association Journal, 2015, v. 9, n. 7/8, p. E507, doi. 10.5489/cuaj.2532
- By:
- Publication type:
- Article
A benchmark comparison of deterministic and probabilistic methods for defining manual review datasets in duplicate records reconciliation.
- Published in:
- Journal of the American Medical Informatics Association, 2014, v. 21, n. 1, p. 97, doi. 10.1136/amiajnl-2013-001744
- By:
- Publication type:
- Article
Effect of Vitamin D Analogues on Acute Cardiorenal Syndrome: A Laboratory Rat Model.
- Published in:
- Israel Medical Association Journal, 2013, v. 15, n. 11, p. 693
- By:
- Publication type:
- Article
Collaborative knowledge acquisition for the design of context-aware alert systems.
- Published in:
- Journal of the American Medical Informatics Association, 2012, v. 19, n. 6, p. 988, doi. 10.1136/amiajnl-2012-000849
- By:
- Publication type:
- Article